This pilot study demonstrated the safety, feasibility, and possible efficacy of psilocybin-assisted group therapy for cancer patients dealing with depressive symptoms.
Read morePsilocybin Therapy for Cancer and Depression
This occurred in patients with both curable and metastatic cancer.
Read morePsychedelics for Cancer
Our current treatments for cancer patients have so many gaps.
It’s time to acknowledge that the answer might lie in unconventional options.
Read morePsilocybin for Late-Stage Cancer
CU Cancer Center researchers are collaborating on NCI-funded research to understand the effects of psilocybin on the depression and anxiety that people with cancer can feel.
Read morePsilocybin, Depression and Cancer
COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed the topline data shared today from an open-label study of psilocybin therapy for depression in cancer patients.
Within one week of a single administration of COMP360 psilocybin therapy, 50% of participants achieved remission in depression symptoms, which was sustained for the eight week follow-up period.
Read morePsilocybin and Terminally Ill Patients
This new study suggests that psilocybin may reduce suicidal thoughts in terminally ill patients.
Read morePsilocybin and Cancer
This study reports that psilocybin provides long-term relief of cancer-related anxiety and depression.
Read moreFilm: A New Understanding
A New Understanding explores the treatment of end-of-life anxiety in terminally ill cancer patients using psilocybin, a psychoactive compound found in some m...